NIGHTINGALE HEALTH OYJ Stock Price, News & Analysis

Nightingale Health SP/ADR (NHLTY) represents American Depositary Receipts (ADRs) of Nightingale Health Oyj, a company that states it has developed what it describes as the world’s most advanced health check. According to the company, its solution focuses on risk detection for multiple chronic diseases using a single blood sample, with an emphasis on scalable, population-level health screening.

The NHLTY ADRs trade on the OTCQX platform under the symbol NHLTY, with each ADR corresponding to one ordinary share of Nightingale Health. The company’s underlying ordinary shares are listed on the Nasdaq Helsinki Stock Exchange under the symbol HEALTH FH. Citi Issuer Services, acting through Citibank N.A., has been appointed as the depositary bank for this sponsored Level 1 ADR program, providing a mechanism for U.S. investors to gain exposure to Nightingale Health’s shares through the OTCQX market.

Business focus and health check solution

Nightingale Health describes its core offering as a health check that can identify risk for multiple chronic diseases from a single blood sample. The company indicates that this approach can replace many existing routine disease risk assessments and health screening programs for chronic diseases. By detecting disease risks comprehensively and efficiently, Nightingale Health aims to enable more effective targeting and tracking of health interventions and to support better prevention of chronic diseases.

The company positions its health check as scalable to entire populations, highlighting its potential use in broad public health and preventive care contexts. This population-level orientation is tied to Nightingale Health’s stated mission to build more sustainable healthcare systems and to reduce health inequalities. The company frames each processed sample as contributing to its goal of creating a healthier world.

ADR program and access for U.S. investors

The sponsored Level 1 ADR program for NHLTY is intended to make Nightingale Health’s shares more accessible to U.S. investors. Through this structure, investors can trade ADRs in U.S. dollars on the OTCQX platform while the underlying ordinary shares continue to trade on Nasdaq Helsinki. Citi, as depositary bank, supports the administration of this ADR program.

Nightingale Health’s leadership has linked the ADR program to its global ambitions and to the importance of the U.S. as a large healthcare market. The company has stated that expanding its business in the U.S. market and providing U.S. investors with greater access to its shares align with its broader global growth strategy.

Mission and healthcare impact

According to Nightingale Health, its mission is to build sustainable healthcare and reduce health inequalities. The company connects its health check solution to this mission by emphasizing early and comprehensive risk detection for chronic diseases. By enabling risk assessment from a single blood sample and aiming to replace multiple existing screening approaches, Nightingale Health presents its technology as a way to support more efficient use of healthcare resources and more targeted preventive measures.

The focus on chronic disease risk, population-level scalability, and health inequality reduction positions Nightingale Health within the broader context of preventive healthcare and public health management. The company highlights that every sample processed contributes to its vision of a healthier world.

Stock information and structure

For investors, it is important to recognize that NHLTY refers to the ADRs traded on OTCQX, while the primary listing of Nightingale Health’s ordinary shares is on Nasdaq Helsinki under the symbol HEALTH FH. Each NHLTY ADR represents one ordinary share of Nightingale Health. The ADR structure provides a way for U.S. market participants to gain exposure to the company without directly trading on the Helsinki exchange.

Because NHLTY is a Level 1 ADR program, it is associated with trading on the OTCQX market rather than on a major U.S. national securities exchange. The depositary bank, Citi, supports the issuance and cancellation of ADRs and related administrative processes.

Considerations for investors and observers

People researching NHLTY may be interested in Nightingale Health’s approach to chronic disease risk detection, its emphasis on scalable health checks, and its stated mission around sustainable healthcare and reducing health inequalities. The relationship between the ADRs and the underlying Helsinki-listed shares is also a key structural feature for understanding how exposure to the company is obtained in different markets.

As with any ADR program, investors may wish to understand the linkage between the ADRs and the underlying ordinary shares, the role of the depositary bank, and the markets on which the securities trade. For Nightingale Health, this includes the OTCQX platform for NHLTY and Nasdaq Helsinki for the HEALTH FH ordinary shares.